Skip to content

Fit Child - Clinical Study on Weight Control

Sopusuhtainen Lapsi - Kliininen Tutkimus Painonhallinnasta

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03196453
Acronym
FITCHI
Enrollment
0
Registered
2017-06-22
Start date
2018-05-25
Completion date
2019-12-31
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutrition Disorder, Child, Overweight, Weight Change, Body

Keywords

overweight, probiotic, weight management

Brief summary

Children with abnormal weight development of BMI will be given either placebo or a probiotic protein formula and measures of weigh gain during a 3-mont treatment will be conducted

Detailed description

In this study, children with abnormal weight development of BMI will be recruited and the gut microbiota will be modified using one of there treatment schedules. The subjects will be divided into three groups 1) receiving a daily drink with protein drink with a probiotic Lactobacillus rhamnosus GG or 2) placebo drink and/or 3) drink with Lactobacillus rhamnosus GG. The children will give a faecal sample in the beginning and at the end and similarly also a blood sample. The faecal sample will be used for analysis of microbiota and differences in microbiota between the groups. Blood samples will be analysed for obesity related biomarkers. Body weight is followed at home and at frequent intervals of the study and analyses made for overweight related biomarkers.

Interventions

DIETARY_SUPPLEMENTProbiotic

probiotic and/or placebo intervention in toddlers

Sponsors

University of Turku
CollaboratorOTHER
Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

double blind, placebo controlled,

Eligibility

Sex/Gender
ALL
Age
2 Years to 5 Years
Healthy volunteers
Yes

Inclusion criteria

2-5 year old child with early weight gain and abnormal BMI, parental concern on weight gain/development \-

Exclusion criteria

Medicines influencing gastric or intestinal function, antibiotic treatment during the last 6 months, use of specific probiotics

Design outcomes

Primary

MeasureTime frameDescription
weight gain3 monthsbody weight

Secondary

MeasureTime frameDescription
Blood biomarkers3 monthsSubar
Weight change3 monthsWeight change

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026